Leucadia National
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Leucadia National's revenues will wane -72.0% and EPS will contract -37.8%.
The average estimate for revenue is $210.7 million. On the bottom line, the average EPS estimate is $0.46.
Revenue details
Last quarter, Leucadia National booked revenue of $2.42 billion. GAAP reported sales were much higher than the prior-year quarter's $202.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, EPS came in at $1.97. GAAP EPS of $1.97 for Q1 were much higher than the prior-year quarter's $0.04 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 22.7%, 2,930 basis points worse than the prior-year quarter. Operating margin was 16.0%, 280 basis points better than the prior-year quarter. Net margin was 20.2%, 1,500 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $870.3 million. The average EPS estimate is $3.24.
Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 1,279 members rating the stock outperform, and 26 members rating it underperform. Among 342 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 337 give Leucadia National a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Leucadia National is hold, with an average price target of $24.00.
- Add Leucadia National to My Watchlist.